Cargando…
Comparison of dobutamine and levosimendan for treatment of sepsis-induced cardiac dysfunction: A protocol for systematic review and meta-analysis
BACKGROUND: Levosimendan and dobutamine are extensively used to treat sepsis-induced cardiomyopathy. Previous studies on whether levosimendan is superior to dobutamine are still controversial. We performed a protocol for systematic review and metaanalysis to compare the efficacy and safety of levosi...
Autores principales: | Guo, Jun, Zhang, Xianhuan, Zhu, Yanan, Cheng, Qiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684197/ https://www.ncbi.nlm.nih.gov/pubmed/35356941 http://dx.doi.org/10.1097/MD.0000000000029092 |
Ejemplares similares
-
Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis
por: Liu, Dong-Hua, et al.
Publicado: (2021) -
Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015) -
Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009) -
An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial
por: Orme, Robert M L’E, et al.
Publicado: (2014) -
Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)